Bio-Rad Laboratories (BIO) Projected to Post Earnings on Thursday

Bio-Rad Laboratories (NYSE:BIO) is anticipated to announce its earnings results after the market closes on Thursday, February 13th. Analysts expect the company to announce earnings of $2.86 per share and revenue of $679.75 million for the quarter. Investors that wish to register for the company’s conference call can do so using this link.

Bio-Rad Laboratories Trading Down 4.6 %

Bio-Rad Laboratories stock opened at $326.36 on Tuesday. The business has a 50 day moving average price of $340.91 and a two-hundred day moving average price of $336.95. The company has a quick ratio of 4.52, a current ratio of 6.14 and a debt-to-equity ratio of 0.16. The stock has a market cap of $9.14 billion, a price-to-earnings ratio of -11.94 and a beta of 0.90. Bio-Rad Laboratories has a 12 month low of $262.12 and a 12 month high of $387.99.

Wall Street Analyst Weigh In

BIO has been the topic of a number of research reports. StockNews.com upgraded Bio-Rad Laboratories from a “hold” rating to a “buy” rating in a report on Friday, November 1st. Royal Bank of Canada reaffirmed an “outperform” rating and set a $481.00 target price on shares of Bio-Rad Laboratories in a report on Tuesday, January 14th. Finally, Citigroup increased their price objective on Bio-Rad Laboratories from $400.00 to $450.00 and gave the company a “buy” rating in a research note on Thursday, October 31st. Two equities research analysts have rated the stock with a hold rating and four have assigned a buy rating to the stock. According to MarketBeat.com, Bio-Rad Laboratories has a consensus rating of “Moderate Buy” and a consensus price target of $394.20.

Bio-Rad Laboratories Company Profile

Bio-Rad Laboratories, Inc manufactures and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. It operates through two segments, Life Science and Clinical Diagnostics. The company develops, manufactures, and markets instruments, systems, reagents, and consumables to separate, purify, characterize, and quantitate biological materials such as cells, proteins, and nucleic acids for proteomics, genomics, biopharmaceutical production, cellular biology, and food safety markets.